Search results for: Determining Value
Filter search results
Can Transparency Lower Prices and Improve Access to Pharmaceuticals? Five Questions We Think Matter a Lot
29 March 2019
…Figure below, two-thirds of the market by value in low and lower middle-income markets included in CGD’s analysis goes to, almost exclusively, branded generics. Further review of data from a…
PROMs and Choice in the NHS
30 March 2010
…was on health care. Policy makers and taxpayers naturally want to know what value patients receive, i.e., whether the output is commensurate with the input. Measuring productivity and value in…
Lung Cancer’s Biggest Test: How Can We Mobilise NGS Testing to Transform Lung Cancer Care?
7 December 2023, 12:00am
Despite recommendations from medical societies, and support for its clinical and economic value, uptake of next-generation sequencing (NGS) has been slow in Europe, and access continues to be an issue….
Around the World in HTAs: United States – Making HTA Great Again
11 June 2024
…processes must consider. The value of HTA in most jurisdictions lies in its consistency in process, and such consistency is a challenge for the US. Methodological and politically-charged disputes impede…
H.R. 3 is the Wrong Policy for the Wrong Problem
10 September 2021
…Medicine which emphasized that: “In the end, drugs that are not affordable are of little value and drugs that do not exist are of no value.” What the US needs…
Making Outcome-Based Payment a Reality in the NHS
2 January 2019
…achieves in practice for NHS patients. OBP could help to accelerate patient access to some new medicines and ensure close monitoring of real-world patient benefit. It can also promote value…
Is It Time to Reconsider the Role of Co-Payments in Europe?
11 January 2012
…about therapy were made primarily by the patient and prescriber, with equity and efficiency issues limiting the usefulness of co-payments. In the ‘new world view’, the decisions about the value…
Spotlight on OHE: Measurement and Valuation of Health Using PROMs
20 December 2012
…requirements of economic evaluation and cost effectiveness analysis. Nancy outlined plans for six new workings groups that will pursue specific research agendas—on value sets, valuation methodology, establishing of a EuroQol data…
Spotlight on OHE: Making Health Care Choices and Decisions
7 January 2013
…value assessment by making the trade offs among value elements explicit and by facilitating the involvement of a range of stakeholders. For those interested in learning more about MCDA, OHE’s…